{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60001123",
    "licUnit": "1",
    "validDate": "2030-03-30 00:00:00.000",
    "issueDate": "2020-03-30 00:00:00.000",
    "oriIssueDate": "2020-03-30",
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000112300",
    "prodNameC": "保癌寧 凍晶注射劑",
    "prodNameE": "Polivy",
    "indicationsName": [
        "1.與rituximab、cyclophosphamide、doxorubicin和prednisone (R-CHP)併用，適用於治療先前未接受過治療之瀰漫性大型B細胞淋巴瘤(DLBCL)成人病人。\r\n2.與bendamustine和rituximab併用，適用於治療復發型(relapsed)或難治型(refractory)且不適合接受造血幹細胞移植的瀰漫性大型B細胞淋巴瘤(DLBCL)病人。"
    ],
    "does": "2243",
    "packageUnit": [
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        },
        {
            "packageSpec": "30毫克、140毫克",
            "packageUnit": "L2"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": "C",
    "mainCategory": "C",
    "drBaseId": "767816AD-741F-495B-9FA7-3404E762244D",
    "subCategory": [
        "C0501"
    ],
    "ingredientsDesc": [
        "polatuzumab vedotin",
        "polatuzumab vedotin"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "07 新藥監視",
        "1S 須執行確認性療效臨床試驗",
        "5F 免除銜接性試驗"
    ],
    "applicantName": "羅氏大藥廠股份有限公司",
    "applicantAddr": "台北市南港區經貿一路170號10樓、10樓之1至之3、10樓之5至之8",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": "2025-03-30",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "0A6135C2-AAF9-401A-9BA4-07C1A0E1D20A",
            "factoryCode": "1",
            "factoryName": "F. HOFFMANN-LA ROCHE LTD.",
            "factoryAddr": "WURMISWEG, CH-4303 KAISERAUGST, SWITZERLAND",
            "factoryCompanyAddr": null,
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "3R",
                    "name": "成品及包裝廠"
                }
            ],
            "processCodeStr": "3R;成品及包裝廠",
            "factoryKind": "M",
            "factoryNo": "FCH0257000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "3D7CC777-7F0A-41C2-BC28-59B36772C840",
            "factoryCode": "1",
            "factoryName": "BSP PHARMACEUTICALS",
            "factoryAddr": "VIA APPIA KM 65,561 04013 LATINA SCALO (LT), ITALY",
            "factoryCompanyAddr": "",
            "countryCode": "IT",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FIT9101000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "45E3F212-D14C-4DB6-891D-9CC62265BF7B",
            "factoryCode": "2",
            "factoryName": "LONZA AG",
            "factoryAddr": "LONZASTRASSE, CH-3930 VISP, SWITZERLAND",
            "factoryCompanyAddr": "",
            "countryCode": "CH",
            "processCode": [
                {
                    "value": "65",
                    "name": "主成分(drug substance)製造廠"
                }
            ],
            "processCodeStr": "65;主成分(drug substance)製造廠",
            "factoryKind": "M",
            "factoryNo": "FCH0292100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013007700",
            "ingredientsName": "polatuzumab vedotin",
            "ingredientsDesc": "polatuzumab vedotin",
            "concentDesc": "",
            "concent": "140.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        },
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013007700",
            "ingredientsName": "polatuzumab vedotin",
            "ingredientsDesc": "polatuzumab vedotin",
            "concentDesc": "",
            "concent": "30.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "2",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01FX14"
        }
    ],
    "licBaseId": "ADF438FC-3C74-4E85-AD68-FE60004FC71F"
}